When attending Dealmakers Summit two sessions stood out: one on hair care and one on skincare. While they both sound completely unrelated, both kept surfacing the same bottleneck: not capital, not consumer demand, but whether a brand has the people to build what the market now demands.
Hair care: from merchandising to medicine
Hair care is growing 5.1% annually, almost entirely on premiumization: people paying more for products that solve real problems. The category's arc, from salon distribution to stylist brands to clean beauty to today's biotech-and-microbiome era, shows a shift from styling to science. Brands are now talking scalp microbiome and follicle biology; GLP-1 use is creating a new hair-thinning consumer; hair transplants have doubled in a decade. One dermatologist-founder built a $75–100M brand in two years on the simple reframe that hair loss is aging, not a disorder.
That's a clinical insight wearing a marketing hat. Investors are explicit about what they're underwriting: real science, defensible IP, and genuine brand loyalty, not one or the other. The winning teams look less like classic CPG hires and more like MDs and cosmetic chemists who can also tell a consumer story. That hybrid talent isn't sitting on the open market; it has to be found and courted out of clinics and labs.
Skincare: six positioning strategies, six different org charts
The skincare panel mapped the category into six archetypes: clinical/professional, prestige experiential, ingredient-driven, prescriptive, esthetic-adjacent, and accessible mass. Each demands a different bench: regulatory and clinical-ops talent for brands running FDA-style trials; chemists who can also explain formulas on TikTok; supply-chain discipline for mass players.
The banker on the panel, who's sold brands like Hero and Starface, put it sharpest: ingredients and data get reverse-engineered fast. The real moat is the convergence of science, distribution, and story, which only exists when a chemist, a clinical lead, and a storyteller are all in the room together. Retail interest in skincare is climbing again in 2026, and every recent deal, Rhode, Byoma, Obagi, Medicube, solved that unification before it solved distribution.
The through-line
A few patterns should shape hiring plans this year:
- Founders are increasingly clinicians and chemists, not just marketers, the scarcest resource in the category.
- The professional channel is shifting to independent operators, which is a field-education staffing problem, not just a go-to-market one.
- DTC now runs on education, not acquisition. Content teams need to translate clinical data, not just run ads.
- AI and personalization are the next hiring wave, as wearables and AI-driven recommendations move from novelty to expectation.
What this means for you
The brands winning deals aren't choosing between science and story, salon and DTC, legacy trust and AI, they're building teams that do all of it at once, often before their Series A. That's a hard team to build off a job posting. It's exactly the hybrid, scientifically-credible-but-commercially-fluent hiring challenge we solve for clients every day at ForceBrands. If your growth plan depends on finding that next dermatologist-founder or chemist-storyteller, let's talk.
